Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 401–500 of 1,000
Use of mouse models in studying type 2 diabetes mellitus
Lee, A. W. S., & Cox, R. D. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001729 · Cited by 36
Type 2 Diabetes Mellitus: New Genetic Insights will Lead to New Therapeutics
Wolfs, M. G. M., Hofker, M. H., Wijmenga, C., & van Haeften, T. W. (2009) · Current Genomics · doi:10.2174/138920209787847023 · Cited by 42
“The KCNJ11 gene is related to permanent neonatal diabetes mellitus (PNDM), a rare form of diabetes starting before the age of 6 months [7].”
BackgroundPharmacogenetics in type 2 diabetes: potential implications for clinical practice
Huang, C., & Florez, J. C. (2011) · Genome Medicine · doi:10.1186/gm292 · Cited by 44
“In one early report, diabetic carriers of the risk K allele at KCNJ11 Glu23Lys were found to have a higher risk for secondary sulfonylurea failure, which was defined as fasting plasma glucose greater than 300 mg/dl despite sulfonylurea treatment followed by sulfonylureamet formin combined therapy [36].”
BackgroundInfluentialThe diabetic β‐cell: hyperstimulated vs. hyperexcited
Nichols, C. G., & Remedi, M. S. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01655.x · Cited by 36
“2 and SUR1 are common causes of transient (TNDM) and permanent (PNDM) human neonatal diabetes [35,36].”
BackgroundChan, K. H. K., Chacko, S. A., Song, Y., Cho, M., Eaton, C. B., Wu, W.-C., & Liu, S. (2015) · Journal of Nutrition · doi:10.3945/jn.114.203489 · Cited by 43
Chen, R., Hussain, K., Alali, M., Dattani, M., Hindmarsh, P. C., Jones, P. M., & Marsh, P. J. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3543 · Cited by 36
Alam, K. A., Svalastoga, P., Martínez, A., Glennon, J. C., & Haavik, J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105301 · Cited by 41
“13 phenotype has been reported in several studies (Gloyn et al. 2004; Hattersley and Ashcroft 2005a; Sagen et al. 2004) where ABCC8 mutation carrier status also is associated with DEND”
BackgroundPawar, A. S., Eirin, A., Krier, J. D., Woollard, J. R., Zhu, X.-Y., Lerman, A., van Wijnen, A. J., & Lerman, L. O. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101423 · Cited by 35
“The KCNJ11 gene encodes for proteins in ATP-sensitive potassium channels, including glucose-stimulated insulin secretion from beta cells, and mutation in this gene may cause neonatal diabetes (49).”
BackgroundA Systematic Review of Childhood Diabetes Research in the Middle East Region
Saraswathi, S., Al‐Khawaga, S., Elkum, N. B., & Hussain, K. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00805 · Cited by 38
“NDM in western countries is caused by defects in the KCNJ11/ABCC8 genes, which encode for the pancreatic beta-cell KATP channel (25).”
BackgroundLau, J., Svensson, J., Grapensparr, L., Johansson, Å., & Carlsson, P. (2012) · Diabetologia · doi:10.1007/s00125-012-2476-6 · Cited by 40
“2 subunit of the ATP-sensitive potassium (KATP) channel have previously been shown to be among the strongest predictors of type 2 diabetes development [32, 33], and heterozygous mutations in this gene cause permanent neonatal diabetes [34].”
BackgroundCurrent understanding of KATP channels in neonatal diseases: focus on insulin secretion disorders
Quan, Y., Barszczyk, A., Feng, Z., & Sun, H. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.57 · Cited by 38
Rabbone, I., Barbetti, F., Marigliano, M., Bonfanti, R., Piccinno, E., Ortolani, F., Ignaccolo, M. G., Maffeis, C., Confetto, S., Cerutti, F., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0828-7 · Cited by 36
Tammaro, P., Proks, P., & Ashcroft, F. M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.099168 · Cited by 35
“In pancreatic β-cells, the reduced ATP sensitivity is expected to increase the whole-cell KATP current, thereby causing membrane hyperpolarization, reduced Ca2+ influx via voltage-gated channels and impairment of insulin secretion (Gloyn et al. 2004).”
BackgroundInfluentialSelf-citationA Meta-Analysis of Bioelectric Data in Cancer, Embryogenesis, and Regeneration
Srivastava, P., Kane, A., Harrison, C., & Levin, M. (2021) · Bioelectricity · doi:10.1089/bioe.2019.0034 · Cited by 37
Yang, L., Zhou, X., Luo, Y., Sun, X., Tang, Y., Guo, W., Han, X., & Ji, L. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0782-6 · Cited by 37
“The importance of KCNJ11 for insulin secretion in humans was supported by the demonstration of its role in familial persistent hyperinsulinemic hypoglycemia of infancy [6] and in permanent neonatal diabetes [ 7 ].”
BackgroundKlupa, T., Kowalska, I., Wyka, K., SKUPIEN, J. K., Patch, A., Flanagan, S. E., Noczyńska, A., Arciszewska, M., Ellard, S., Hattersley, A. T., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03478.x · Cited by 36
Self-citationBenninger, R. K. P., Remedi, M. S., Head, W. S., Ustione, A., Piston, D. W., & Nichols, C. G. (2011) · Diabetologia · doi:10.1007/s00125-010-2039-7 · Cited by 36
“In humans, such ‘gain-of-function’ mutations are the most common cause of neonatal diabetes mellitus [3].”
Clinical, Genetic, and Biochemical Characteristics of Early-Onset Diabetes in the Finnish Population
Huopio, H., Miettinen, P. J., Ilonen, J., Nykänen, P., Veijola, R., Keskinen, P., Näntö‐Salonen, K., Vangipurapu, J., Raivo, J., Stančáková, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4296 · Cited by 40
Tricarico, D., Selvaggi, M., Passantino, G., Palo, P. D., Dario, C., Centoducati, P., Tateo, A., Curci, A., Maqoud, F., Mele, A., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00167 · Cited by 34
The Shifting Landscape of KAtpChannelopathies and the Need for ‘Sharper’ Therapeutics
Kharade, S. V., Nichols, C. G., & Denton, J. S. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0005 · Cited by 38
Taneja, T. K., Mankouri, J., Karnik, R., Kannan, S., Smith, A. J., Munsey, T. S., Christesen, H. T., Beech, D. J., & Sivaprasadarao, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp179 · Cited by 39
“(gain of function) lead to neonatal diabetes mellitus (NDM) (OMIM 606176), where insulin secretion is seriously compromised with severe hyperglycaemia (6,7).”
BackgroundDominant versus recessive: Molecular mechanisms in metabolic disease
Zschocke, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1016-5 · Cited by 33
Maassen, J. A., Jahangir Tafrechi, R. S., Janssen, G. M. C., Raap, A. K., Lemkes, H. H., & ’t Hart, L. M. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.02.014 · Cited by 33
Fendler, W., Pietrzak, I., Brereton, M. F., Lahmann, C., Gadzicki, M., Bienkiewicz, M., Drozdz, I., Borowiec, M., Malecki, M. T., Ashcroft, F. M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2166 · Cited by 33
“2, KCNJ11) or regulatory (SUR1, ABCC8) subunits of the ATP-sensitive K (KATP) channel (1).”
BackgroundSelf-citationMetabolic Syndrome and Ionic Channels in Pancreatic Beta Cells
Hiriart, M., Velasco, M., Larqué, C., & Díaz‐García, C. M. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00004-1 · Cited by 41
“NDM is defined as the insulin-requiring monogenic diabetes that presents during the first 6 months of life and can be transient or permanent.”
BackgroundInfluentialFranco, E. D. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.08.016 · Cited by 36
“2 or SUR1 (KCNJ11 or ABCC8) can be treated with high dose sulphonylureas [5, 6].”
BackgroundInfluentialBattaglia, D., Lin, Y.-W., Brogna, C., Crinò, A., Grasso, V., Mozzi, A. F., Russo, L., Spera, S., Colombo, C., Ricci, S., et al. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00874.x · Cited by 32
“The combination of diabetes with neurological symptoms prompted investigation of the KCNJ11 gene (3), by DNA direct sequencing as described (1, 5); the mutation was then confirmed on individual clones after TA-TOPO cloning.”
BackgroundDifferential diagnosis of type 1 diabetes: which genetic syndromes need to be considered?
Barrett, T. G. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00278.x · Cited by 34
“shown to be the most common cause of diabetes presenting under 6 months of age (11) (Fig.”
BackgroundZwaveling‐Soonawala, N., Hagebeuk, E. E. O., Slingerland, A. S., Ris‐Stalpers, C., Vulsma, T., & van Trotsenburg, A. S. P. (2010) · Diabetologia · doi:10.1007/s00125-010-1981-8 · Cited by 33
Self-citationEngineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels
Pratt, E. B., Zhou, Q., Gay, J. W., & Shyng, S.-L. (2012) · Journal of General Physiology · doi:10.1085/jgp.201210803 · Cited by 35
“Most of them reduced channel ATP sensitivity just as numerous other mutations that have been reported before (Tucker et al., 1998; Enkvetchakul et al., 2000; Loussouarn et al., 2001; Cukras et al., 2002; Gloyn et al., 2004; Proks et al., 2004).”
BackgroundIon Channel Modulators and Urinary Tract Function
Brading, A. F., & Brain, K. L. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-16499-6_18 · Cited by 33
Malecki, M. T., SKUPIEN, J. K., Klupa, T., Wanic, K., Mlynarski, W. M., Gach, A., Solecka, I., & Sieradzki, J. (2006) · Diabetes Care · doi:10.2337/dc06-1628 · Cited by 33
“2 were reported (1) as the most common cause of permanent neonatal diabetes (PND).”
BackgroundMcCarthy, M. I., & Zeggini, E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0026-7 · Cited by 34
De Franco, E., Caswell, R., Houghton, J. A. L., Iotova, V., Hattersley, A. T., & Ellard, S. (2017) · Diabetic Medicine · doi:10.1111/dme.13180 · Cited by 31
Self-citationPrecision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
Galiero, R., Caturano, A., Vetrano, E., Monda, M., Marfella, R., Sardu, C., Salvatore, T., Rinaldi, L., & Sasso, F. C. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s390752 · Cited by 41
The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy
Sandal, T., Laborie, L., Brusgaard, K., Eide, S., Christesen, H. T., Søvik, O., Pr, N., & Molven, A. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01152.x · Cited by 37
“All samples screened for ABCC8 mutations were also sequenced for alterations in KCNJ11 as described previously (13).”
BackgroundPractical Aspects of Monogenic Diabetes: A Clinical Point of View
Lachance, C.-H. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.11.004 · Cited by 37
Ion Transporters, Channelopathies, and Glucose Disorders
Demirbilek, H., Galcheva, S., Vurallı, D., Al‐Khawaga, S., & Hussain, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102590 · Cited by 35
Aging as a loss of morphostatic information: A developmental bioelectricity perspective
Pio‐Lopez, L., & Levin, M. G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102310 · Cited by 41
Cane, M. C., Parrington, J., Rorsman, P., Galione, A., & Rutter, G. A. (2015) · Cell Calcium · doi:10.1016/j.ceca.2015.12.004 · Cited by 31
Nichols, C. G., York, N., & Remedi, M. S. (2022) · Diabetes · doi:10.2337/db21-0755 · Cited by 34
Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes
Hartemann, A., Simon, A., Bellanné‐Chantelot, C., Reynaud, R., Cavé, H., Polak, M., Vaxillaire, M., & Grimaldi, A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.01.003 · Cited by 31
Monogenic Diabetes: A Diagnostic Algorithm for Clinicians
Carroll, R. W., & Murphy, R. (2013) · Genes · doi:10.3390/genes4040522 · Cited by 34
“2 and SUR1 subunits respectively [9–11].”
BackgroundKooptiwut, S., Plengvidhya, N., Chukijrungroat, T., Sujjitjoon, J., Semprasert, N., Furuta, H., & Yenchitsomanus, P. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.025 · Cited by 31
“development and function (Gloyn et al., 2004; Habener, Kemp, & Thomas, 2005; Hattersley et al., 1992; Perry & Frayling, 2008; Stoffers, Ferrer, Clarke, & Habener, 1997).”
Pearson, E. R. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0028-3 · Cited by 35
“Sulfonylureas bind to the K ATP channel, and intravenous tolbutamide was able to stimulate insulin secretion in patients with KCNJ11 mutations [ 20 ].”
BackgroundSelf-citationCognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes
Bowman, P., Day, J. O., Torrens, L., Shepherd, M. H., Knight, B., Ford, T. J., Flanagan, S. E., Chakera, A. J., Hattersley, A. T., & Zeman, A. Z. (2018) · Diabetes Care · doi:10.2337/dc18-1060 · Cited by 34
“In the pancreas, the KATP channel links increasing blood glucose to insulin secretion, but activating KCNJ11 mutations prevent channel closure in response to metabolically generated ATP and result in diabetes (2).”
BackgroundSelf-citationThe clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar
Al‐Khawaga, S., Mohammed, I., Saraswathi, S., Haris, B., Hasnah, R., Saeed, A. Z., Almabrazi, H., Syed, N., Jithesh, P. V., Awwa, A. E., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.753 · Cited by 35
“These mutations account for 31% and 10% of all PNDM cases, respectively (Babenko et al., 2006; Gloyn et al., 2004).”
BackgroundSulfonylurea Treatment in Young Children With Neonatal Diabetes
Ethel Codner, D., Flanagan, S. E., Ugarte, F., García, H., Vidal, T., Ellard, S., & Hattersley, A. T. (2007) · Diabetes Care · doi:10.2337/dc06-2134 · Cited by 31
“Recently, heterozygous activating mutations in the genes forming the ATPsensitive potassium channel, KCNJ11 and ABCC8, have been shown to cause neonatal diabetes (1-4).”
BackgroundSelf-citationRutter, G. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12579 · Cited by 34
Vedovato, N., Cliff, E. R. S., Proks, P., Varadarajan, P., Flanagan, S. E., Ellard, S., Hattersley, A. T., & Ashcroft, F. M. (2016) · Diabetologia · doi:10.1007/s00125-016-3964-x · Cited by 34
“the sulfonylurea receptor [SUR] 1) subunits of the ATPsensitive potassium (KATP) channel [1–3].”
BackgroundSelf-citationGraff, S. M., Johnson, S. R., Leo, P. J., Dadi, P. K., Dickerson, M. T., Nakhe, A. Y., McInerney-Leo, A. M., Marshall, M. S., Zaborska, K. E., Schaub, C. M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.138057 · Cited by 46
“For example, gainof-function mutations in KATP channel subunits hyperpolarize the β cell membrane potential (Vm), reducing VDCC activity, Ca2+ influx, and GSIS (8, 9).”
BackgroundThe Genetics of Diabetes: What We Can Learn from Drosophila
Liguori, F., Mascolo, E., & Vernì, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011295 · Cited by 36
A roadmap to achieve pharmacological precision medicine in diabetes
Florez, J. C., & Pearson, E. R. (2022) · Diabetologia · doi:10.1007/s00125-022-05732-3 · Cited by 30
“dominant familial diabetes in a young and lean person, with a non-ketotic and antibody-negative presentation), the diagnosis triggers a genetic test for the specific molecular subtype, and the result determines whether the patient can be transitioned from insulin to high-dose sulfonylurea (in the case of neonatal diab…”
BackgroundSelf-citationPersonalized Therapeutics for KATP-Dependent Pathologies
Nichols, C. G. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-123023 · Cited by 37
New insights from monogenic diabetes for “common” type 2 diabetes
Tallapragada, D. S. P., Bhaskar, S., & Chandak, G. R. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00251 · Cited by 35
“More than 50% of PNDM cases are due to activating mutations in KCNJ11 and ABCC8, while majority of mutations genes associated with PNDM are de novo in origin (Gloyn et al., 2004; Babenko et al., 2006; Edghill et al., 2010).”
BackgroundHaspel, D., Krippeit‐Drews, P., Aguilar‐Bryan, L., Bryan, J., Drews, G., & Düfer, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1720-8 · Cited by 31
“Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA in Kir6.2 can produce neonatal diabetes [ 14 ].”
BackgroundGenetics of type 2 diabetes mellitus and obesity—a review
Jafar‐Mohammadi, B., & McCarthy, M. I. (2008) · Annals of Medicine · doi:10.1080/07853890701670421 · Cited by 35
“Fourth, rare variants in both genes have been implicated in monogenic syndromes (of insulin resistance, and neonatal diabetes, respectively), illustrating the potential for a spectrum of phenotypes associated with varying degrees of functional disturbance (19,51).”
BackgroundThe ATP-Sensitive K+ Channel ABCC8 S1369A Type 2 Diabetes Risk Variant Increases MgATPase Activity
Fatehi, M., Raja, M., Carter, C., Soliman, D., Holt, A., & Light, P. E. (2011) · Diabetes · doi:10.2337/db11-0371 · Cited by 35
Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. B. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.95 · Cited by 35
Antosik, K., & Borowiec, M. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0432-8 · Cited by 34
“2 subunit of the KATP channels, initiating channels closure, membrane depolarization and insulin secretion (Lang and Light 2010).”
BackgroundInfluentialKir6.1 and SUR2B in Cantú syndrome
McClenaghan, C., & Nichols, C. G. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2022 · Cited by 33
Harsunen, M. H., Kettunen, J. L. T., Härkönen, T., Dwivedi, O. P., Lehtovirta, M., Vähäsalo, P., Veijola, R., Ilonen, J., Miettinen, P. J., Knip, M., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05834-y · Cited by 29
“(Arg201His) can also cause KCNJ11-MODY with variable onset and severity of diabetes [24, 25].”
BackgroundATP-Sensitive Potassium Channels in Health and Disease
Clark, R. H., & Proks, P. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_8 · Cited by 36
Self-citationAcquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management
Porter, J. R., & Barrett, T. G. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.036608 · Cited by 30
Tammaro, P., Flanagan, S. E., Zadek, B., Srinivasan, S., Woodhead, H., Hameed, S. A., Klimeś, I., Hattersley, A. T., Ellard, S., & Ashcroft, F. M. (2008) · Diabetologia · doi:10.1007/s00125-008-0923-1 · Cited by 32
“2R201H channels are from [14], for Y330C and F333I from [26], for Q52R, V59G and R201C from [15], for V59M from [24], for I296L from [16] and for G334D from [34] 808 Diabetologia (2008) 51:802–810”
BackgroundSelf-citationGlibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes
Beltrand, J., Baptiste, A., Busiah, K., Bouazza, N., Godot, C., Boucheron, A., Djerada, Z., Gozalo, C., Berdugo, M., Tréluyer, J., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12823 · Cited by 28
Flechtner, I., de Lonlay, P., & Polak, M. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70311-7 · Cited by 28
Inherited destiny? Genetics and gestational diabetes mellitus
Watanabe, R. M. (2011) · Genome Medicine · doi:10.1186/gm232 · Cited by 35
Lu, M. H., & Li, C. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13448 · Cited by 29
K channels “vingt ans après”: ATG to PDB to Mechanism
Babenko, A. P. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.12.004 · Cited by 28
Disease Associated Mutations in KIR Proteins Linked to Aberrant Inward Rectifier Channel Trafficking
Zangerl‐Plessl, E., Qile, M., Bloothooft, M., Stary‐Weinzinger, A., & van der Heyden, M. A. G. (2019) · Biomolecules · doi:10.3390/biom9110650 · Cited by 28
“2 [50] whose cause for loss- and gain-offunction, respectively, is unknown but may be caused by trafficking abnormalities.”
BackgroundABCC8 Polymorphism (Ser1369Ala): Influence on Severe Hypoglycemia due to Sulfonylureas
Sato, R., Watanabe, H., Genma, R., Takeuchi, M., Maekawa, M., & Nakamura, H. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.135 · Cited by 27
Flagg, T. P., Patton, B. L., Masia, R., Mansfield, C., Lopatin, A. N., Yamada, K. A., & Nichols, C. G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00011.2007 · Cited by 28
“2 cause severe neonatal diabetes (14, 19) due to increased KATP channel activity in pancreatic -cells.”
BackgroundA Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction
Merino, J., Udler, M. S., Leong, A., & Meigs, J. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0958-0 · Cited by 35
A New Drug Target for Type 2 Diabetes
Stadler, L. K. J., & Farooqi, I. S. (2017) · Cell · doi:10.1016/j.cell.2017.06.024 · Cited by 26
“Therapies targeting MCT11 may be particularly effective in people whose T2D is driven by this mechanism/ pathway as seen in monogenic forms of diabetes where patients are particularly responsive to certain classes of anti-diabetic drugs (Gloyn et al., 2004; Pearson et al., 2003).”
BackgroundFailed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02
Simmons, K. M., Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Baschal, E. E., Armstrong, T., Pyle, L. L., Yu, L., & Michels, A. W. (2020) · Diabetes · doi:10.2337/db20-0038 · Cited by 29
“2 (KCNJ11), which are known to cause neonatal diabetes (26) (Supplementary Table).”
BackgroundDemirci, D. K., Darendelıler, F., Poyrazoğlu, Ş., Kardelen, A. D., Gül, N., Tütüncü, Y., Gülfidan, G., Arğa, K. Y., Cacına, C., Öztürk, O., et al. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0081 · Cited by 27
“The ABCC8 gene encodes the sulfonylurea (SU) receptor 1 subunit of K-ATP (Bonnefond et al., 2012; Gloyn et al., 2004; Vaxillaire et al., 2004).”
Comparison of K+ Channel Families
Taura, J. J., Kircher, D. M., Gameiro‐Ros, I., & Slesinger, P. A. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_460 · Cited by 34
Männikkö, R., Flanagan, S. E., Sim, X., Segal, D. G., Hussain, K., Ellard, S., Hattersley, A. T., & Ashcroft, F. M. (2011) · Diabetes · doi:10.2337/db10-1583 · Cited by 29
Self-citationMyngheer, N., Allegaert, K., Hattersley, A., McDonald, T., Kramer, H., Ashcroft, F. M., Verhaeghe, J., Mathieu, C., & Casteels, K. (2014) · Diabetes Care · doi:10.2337/dc14-1247 · Cited by 24
Self-citationFuture Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity
Bowman, P., Flanagan, S. E., & Hattersley, A. T. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3061620 · Cited by 28
“Another possible reason for the incomplete CNS response to sulphonylurea treatment in people with KCNJ11 PNDM is that therapeutic concentrations of sulphonylurea are not achieved in the human CSF.”
BackgroundInfluentialSelf-citationThe role of membrane excitability in pancreatic β-cell glucotoxicity
Shyr, Z. A., Wang, Z., York, N., Nichols, C. G., & Remedi, M. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43452-8 · Cited by 31
Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K
Flagg, T. P., Remedi, M. S., Masia, R., Gomes, J. D. F., McLerie, M., Lopatin, A. N., & Nichols, C. G. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.06.003 · Cited by 29
Continuous subcutaneous insulin infusion in neonatal diabetes mellitus
Wintergerst, K. A., Hargadon, S., & Hsiang, H. Y. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00067.x · Cited by 26
“adenosine triphosphate (ATP)-sensitive potassium (KATP) channel, which regulates glucose-stimulated insulin secretion from pancreatic beta-cells (17).”
BackgroundKoster, J. C., Remedi, M. S., Masia, R., Patton, B. L., Tong, A., & Nichols, C. G. (2006) · Diabetes · doi:10.2337/db06-0732 · Cited by 28
“In the most severe cases, NDM is part of a neurological syndrome that includes developmental delay, epilepsy, and neonatal diabetes (3,11).”
BackgroundInfluentialFrom congenital hyperinsulinism to diabetes mellitus: the role of pancreatic beta-cell KATP channels
Hussain, K., & Cosgrove, K. E. (2005) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2005.00109.x · Cited by 28
Zhou, Q., Chen, P., Devaraneni, P. K., Martin, G. M., Olson, E. M., & Shyng, S. (2014) · Channels · doi:10.4161/chan.29117 · Cited by 28
Genetics of Type 2 Diabetes: Opportunities for Precision Medicine
Kim, D. S., Gloyn, A. L., & Knowles, J. W. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.346 · Cited by 27
Self-citationClinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review
Li, M., Han, X., & Ji, L. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9479268 · Cited by 29
Genome, Exome, and Targeted Next-Generation Sequencing in Neonatal Diabetes
Franco, E. D., & Ellard, S. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.04.012 · Cited by 26
Self-citationEl‐Sisi, A. E., Hegazy, S. K., Metwally, S. S., Wafa, A. M., & Dawood, N. A. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811415985 · Cited by 25
“2 produces permanent neonatal diabetes, whereas loss-of-function polymorphisms in KCNJ11 have been associated with familial hyperinsulinemic hypoglycemia of infancy [Gloyn et al. 2004; Miki et al. 1998; Nestorowicz et al. 1997].”
BackgroundKoster, J. C., Kurata, H. T., Enkvetchakul, D., & Nichols, C. G. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.138685 · Cited by 27
The physiology of rodent beta‐cells in pancreas slices
Rupnik, M. S. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01927.x · Cited by 27
“It is now widely accepted that defects in KATP channels may also contribute to insufficient insulin release and diabetes mellitus (Koster et al. 2000, Gloyn et al. 2004).”
BackgroundEvliyaoğlu, O., Ercan, O., Ataloğlu, E., Zübarioğlu, Ü., Özcabı, B., Çakır, A. D., Erdoğan, H. Ç., Franco, E. D., & Ellard, S. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.5162 · Cited by 28
Self-citationMonogenic diabetes: the impact of making the right diagnosis
Harris, A. G., Letourneau, L. R., & Greeley, S. A. W. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000643 · Cited by 27
“All rights rese Dominant heterozygous mutations in KCNJ11 are the most common cause of permanent neonatal diabetes in nonconsanguineous families [7,10], followed by mutations in the insulin gene (INS) [11,12].”
BackgroundMonogenic Forms of Diabetes Mellitus
Gaál, Z., & Balogh, I. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_18 · Cited by 31
Neonatal hyperglycaemia and abnormal development of the pancreas
Flechtner, I., Vaxillaire, M., Cavé, H., Scharfmann, R., Froguel, P., & Polak, M. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.08.003 · Cited by 27
Defining the genetic aetiology of monogenic diabetes can improve treatment
Gloyn, A. L., & Ellard, S. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.13.1759 · Cited by 27
“This reduction in ATP sensitivity leads to a failure of the generation ATP by the metabolism of glucose that is required in order to close the KATP channel and initiate insulin secretion [48].”
BackgroundSelf-citationHuman genetics as a model for target validation: finding new therapies for diabetes
Thomsen, S. K., & Gloyn, A. L. (2017) · Diabetologia · doi:10.1007/s00125-017-4270-y · Cited by 27
“Genetic studies on PNDM has led to the realisation that a subset of individuals harbour mutations in the genes encoding the KATP channel [65].”
BackgroundSelf-citationNeonatal diabetes caused by disrupted pancreatic and β‐cell development
Franco, E. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14728 · Cited by 24
“Some genes however can cause all three types of neonatal diabetes, for example pathogenic activating variants in KCNJ11 and ABCC8, can cause either transient, isolated neonatal, or syndromic neonatal diabetes (DEND syndrome) [5-9].”
Background
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.